Qynapse
About:
Qynapse leverages neuroimaging & AI to advance the accuracy and reliability of Central Nervous System diseases screening and monitoring.
Website: http://www.qynapse.com/
Twitter/X: qynapse
Top Investors: AGORANOV
Description:
Qynapse is on a mission to advance the accuracy and reliability of Central Nervous System (CNS) diseases screening and monitoring in both clinical routine settings and in clinical trial applications. We combine MRI scans and AI to produce rapid, actionable insights.The company is headquartered in France, in the United States and in Canada.
$6.6M
$1M to $10M
Paris, Ile-de-France, France
2015-01-01
contact(AT)qynapse.com
Olivier Courrèges
11-50
2021-06-24
Private
© 2025 bioDAO.ai